NORTH CHICAGO, Ill., Nov. 30, 2021 /PRNewswire/ -- AbbVie (NYSE:ABBV) today announced it has submitted an application to the European Medicines Agency (EMA) seeking approval for risankizumab (SKYRIZI®, 600 mg intravenous (IV) induction and 360 mg subcutaneous (SC) maintenance therapy), an interleukin-23 (IL-23) inhibitor, for the treatment of patients 16 years and older with moderate to severe active Crohn's disease who have had inadequate response, lost response or were intolerant to conventional or biologic therapy. The submission is supported by three pivotal Phase 3 studies, ADVANCE, MOTIVATE and FORTIFY.1,2
6:59:00 AM ET — via Accenture
Accenture to Host Conference Call Thursday, Dec. 16, to Discuss First-Quarter Fiscal Year 2022 Results
NEW YORK; Nov. 30, 2021 – Accenture (NYSE: ACN) will host a conference call at 8:00 a.m. EST on Thursday, Dec. 16, to discuss its first-quarter fiscal year 2022 financial results. A news release containing these results will be issued before the call.
3:57:00 AM ET — via AbbVie
The Alliance for Endometriosis Survey Reveals Actions Needed to Improve the Endometriosis Patient Experience
Today, the Alliance for Endometriosis announced findings from a national public survey that shed light on people’s experiences with endometriosis-related stigma and the disconnect in conversations between patients and health care professionals.
7:31:00 PM ET — via Accenture
Accenture Announces Extended Relationship with AWS and Joint Investments to Help Organizations Get to Cloud Value Faster
Las Vegas, Nevada, Nov. 29, 2021 – Accenture (NYSE: ACN) today announced the renewal of its joint business group with Amazon Web Services, Inc. (AWS). Building on a 13-year relationship, Accenture and AWS will make an additional joint investment over the next five years to help clients spur innovation on the Cloud Continuum and accelerate business value at scale by delivering solutions through the Accenture AWS Business Group (AABG).
3:41:00 PM ET — via Ameriprise Financial
A Wave of Uncertainty Hits Markets as a New Virus Variant is Detected
News of a new Covid strain of concern sent a wave of apprehension through markets on Friday. Worried that another winter of mobility restrictions could once again dramatically slow global economic activity, investors chose to dump stocks and seek the protection of safe haven assets, despite knowing little about the new so-called Omicron variant. The MSCI All-Country World index plunged 2.2 percent on the day. Stocks in the U.S. fell by a similar amount, and the VIX index spiked higher from 18.6 to 28.6. European markets, already dealing with an infection surge from the Delta variant, got hammered, as the EuroStoxx 50 index fell 4.7 percent. Brent crude oil plunged $9.50, or 12 percent, a barrel. The yield on the ten-year Treasury note fell 16 basis points to 1.47 percent, and the two-year note yield fell from 0.60 to 0.48 percent.
12:12:00 PM ET — via Delaware North
Delaware North chefs share Thanksgiving recipes
We're sharing some of our favorite Thanksgiving recipes from Delaware North chefs and restaurant locations for you to try at home.
11:21:00 AM ET — via Delaware North
UBS Arena opens with fanfare, flurry of events
11:00:00 AM ET — via Vail Resorts
Dec. 5 is the last chance to purchase an Epic Pass for 2021-22 ski and ride season
• 2021-22 Epic Pass products go off sale at 11:59 p.m. MT on Dec. 5; with a 20 percent price reset, the Epic Pass is currently available for $879 • Lift tickets will be limited during three holiday periods; Dec. 5 is the last chance to lock in an Epic Day Pass
8:11:00 AM ET — via AbbVie
AbbVie to Present at the Evercore ISI Conference
NORTH CHICAGO, Ill., Nov. 23, 2021 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the 4th Annual Evercore ISI Virtual HealthCONx Conference on Thursday, December 2, 2021. Michael Severino, M.D., vice chairman and president, Robert A. Michael, executive vice president and chief financial officer, and Jeffrey R. Stewart, executive vice president, commercial operations, will present at 11:10 a.m. CT.
8:11:00 AM ET — via AbbVie
AbbVie to Present at the Piper Sandler Healthcare Conference
NORTH CHICAGO, Ill., Nov. 23, 2021 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference on Wednesday, December 1, 2021. Michael Severino, M.D., vice chairman and president, Robert A. Michael, executive vice president and chief financial officer, and Jeffrey R. Stewart, executive vice president, commercial operations, will present at 9:30 a.m. CT.
4:26:00 PM ET — via Ameriprise Financial
Equities Shake Off Inflation Concerns – Can it Last?
The chorus of those warning about the rise in inflation seems to be getting louder. Two weeks ago, as they have been for some time, St. Louis Fed President Bullard and former Treasury Secretary Summers were among the more prominent voices warning that the Fed risks falling behind the curve. Last week, Fed Vice Chair Clarida said a faster taper schedule could be a topic for discussion at upcoming meetings. Atlanta Fed President Bostick said it may be appropriate to begin normalizing interest rates by the middle of next year. West Virginia Senator Manchin has cited inflation fears as contributing to his concern about the Build Back Better bill. And a number of prominent business leaders have warned about the rising danger of inflation as well.
4:00:00 AM ET — via Motorola
Motorola Solutions Showcases Integrated Technology Ecosystem at PMRExpo 2021 in Cologne, Germany
7:13:00 PM ET — via Walgreens
Walgreens Now Providing All COVID-19 Vaccine Boosters for Individuals Ages 18 and Older
Walgreens announced today that all individuals over the age of 18 can now receive a Pfizer, Moderna or Johnson & Johnson COVID-19 vaccine booster in stores nationwide.
4:33:00 PM ET — via Delaware North
Astronaut Hall of Fame at Kennedy Space Center Visitor Complex inducts new membership class
The U.S. Astronaut Hall of Fame this week inducted three new members as its 19th class of honorees at the Delaware North-operated Kennedy Space Center Visitor Complex.
IRVINE, Calif., Nov. 19, 2021 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company, (NYSE: ABBV) today announced that it will present six abstracts from its leading portfolio of aesthetic treatments and products at the American Society for Dermatologic Surgery (ASDS) meeting taking place virtually November 19-21, 2021.
7:54:00 AM ET — via AbbVie Stories
They won’t back down
5 courageous voices on why investment in new medicines matters.
10:39:00 PM ET — via Accenture
Accenture Completes Acquisition of BRIDGEi2i
BENGALURU, India; Nov. 18, 2021 – Accenture (NYSE: ACN) has completed its acquisition of BRIDGEi2i, an artificial intelligence (AI) and analytics firm headquartered in Bengaluru, India. The financial terms of the transaction were not disclosed.
8:14:00 PM ET — via Accenture
Accenture to Acquire Tambourine to Strengthen its World-Class Commerce Transformation Capabilities in Japan
TOKYO; Nov. 18, 2021 – Accenture (NYSE: ACN) has agreed to acquire Tambourine, an e-commerce customer experience agency with award-winning capabilities in cloud-based technologies in Japan. Tambourine brings a proven track record in using Salesforce Commerce Cloud to deliver seamless commerce experiences for consumer goods and entertainment companies. Terms of the transaction were not disclosed.